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CENTER OF EXCELLENCE FOR LIVESTOCK DISEASES AND HUMAN
HEALTH
COLLEGE OF VETERINARY MEDICINE
UNIVERSITY OF TENNESSEE
The Center of Excellence for Livestock Diseases and Human Health has had a significant
role in addressing the needs of animal agriculture in Tennessee and in providing a unique
dimension to human health research. The College of Veterinary Medicine has been a true
pioneer in the use of animal models to investigate several animal diseases and recently
has provided leadership in using laboratory models and thereby reducing the number of
animals used in research. It is unlikely that significant progress in the understanding of
these diseases could have been made if these animal and laboratory models had not been
available. The mission of this Center of Excellence is indeed very important. Within the
broad research definition ofthe Center, the following five areas have been emphasized:
Host Defense
Infectious diseases/population medicine
Molecular genetics and carcinogenesis
Reproduction
Toxicology
The center has established the following goals:
1.

2.
3.
4.

5.

6.
7.
8.

..
..
..
.

9.
10.
11.

To improve the quality ofhuman life by improving animal health.
To augment livestock disease research capabilities in the Institute of
Agriculture.
To identify and characterize laboratory and animal models of important
human diseases.
To study animal/laboratory models for better understanding of human
health.
To study the mechanisms of disease development and characterize
causative agents of common diseases important to the State of Tennessee.
To improve the capabilities of the College of Veterinary Medicine, the
College of Agricultural Sciences and Natural Resources and the
Agricultural Experiment Station to manage these diseases.
To improve the facilities to enable the College of Veterinary Medicine to
study more effectively infectious and toxic diseases of animals.
To disseminate through the Extension Service practical information
required to reduce the incidence oflivestock diseases.
To develop new strategies for the prevention of disease.
To improve facilities and expertise to enhance research training.
To develop innovative approaches to the treatment of human diseases.

The Center of Excellence has made a significant contribution to each of these goals and
are documened in this "Program Report" and in the description of "Core Laboratory"
activities. Performance metrics with respect to scientific publications, presentations and
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extramural funding have exceeded benchmarks to impressive degrees (see tables on
benchmarks and funding). In the most recent fiscal year, 1999-2000, the return of the
State's investment in the Center was almost six fold, a record for the Center (see
"FWlding Levels"). The number of scientific commWlications in the form of refereed
publications by Center-based investigators for the reporting period 1995 - 2000 was
excellent (an average of7.9 per participant per year).
Research results have been disseminated to fellow scientists in prestigious, refereed
international journals and to stakeholders in popular journals and magazines distributed
regionally and nationally. Numerous invitations have been extended to many faculty in
the Center to make keynote/plenary presentations at national/international scientific
meetings. They include Drs. D.A. Brian, B.T. Rouse, J. Oliver, S. Oliver, H.M. Schuller
and T.W. Schultz.
This report features the accomplishments and activities of investigators and
research teams that constitute the core of the Center. Their achievements serve a crucial
function in promoting the College of Veterinary Medicine, the Institute for Agriculture
and the University of Tennessee. Furthermore, they continue to ensure that the Center
maintains its strong competitive position and contribute to the fiscal health of our
research environment. The report endeavors to emphasize the strength of the Center and
give a clear indication ofhow it meets its objectives.
Accomplishments

The accomplishments and activities of "Core Laboratories" in the Center are
summarized in this report in a manner that can be appreciated by a wide readership.
Accomplishments can be measured in a variety of ways and include peer-reviewed
scientific publications, leverage of the Center in attracting appropriate extramural
funding, the number of national/international presentations by participants, effective
dissemination of discovery in the Center, the number of scientists brought to the
University to foster scientific collaboration/communication, training of scientists and
other benchmarks (see tables on funding and benchmarks). Center of Excellence faculty
published an impressive 728 peer-reviewed scientific articles over the reporting period of
1995-2000. This represents an average of 7.9 per year per participant, a truly remarkable
achievement. Furthermore, these faculty made 326 presentations at national/international
scientific meetings over the reporting period. Please see the discussions on "Funding
Levels", "Research FWlding", "Research Training", "Culture for Discover",
"Dissemination of Research to the General Public", "Personnel Changes" and details on
the activities in "Core Laboratories" for more information on achievements.
Research Funding

The "core" members of the Center of Excellence are Drs. Barry Rouse, Hildegard
Schuller, David Brian, Terry Schultz, Jim Godkin, Steve Oliver, Jack Oliver, Xuemin Xu
and Hwa-Chain Wang. Included among this group are several pre-eminent scientists
with international reputations for excellence. They include Drs. Rouse, Schuller, Brian,
Jack Oliver, Steve Oliver and Schultz. These investigators are established researchers
and have a superior record of extramural funding and scholarship that spans over two
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decades. The core members contribute most of the benchmarks of the Center and have an
important leadership role in the program.
An important goal of the Center of Excellence in Livestock Diseases and Human
Health is to support researchers and to promote research by a variety of mechanisms.
State fiscal restraints for several years have restricted our ability to recruit and hire
competitive researchers. The Center has had a significant impact over the last two years
in recruitment of researchers with ongoing research programs. The existence of the
Center and its ability to contribute to start-up packages has made the difference in these
recruitment efforts.
The Center of Excellence emphasizes the following six specific areas: Infectious
Diseases/Population Medicine, Toxicology, Reproduction, Host Defense and Molecular
Genetics and Carcinogenesis. Each participant contributes to at least one of these areas
of emphasis. The Center's underlying philosophy is to enhance the capacity of young or
new investigators to compete for extramural funding and to assist established researchers
in maintaining extramural support. The Center does not serve as a primary source of
research funding for faculty. The main criteria used for funding proposals include
scientific merit, likelihood of leading to extramural funding and relevance to the Center's
objectives. Proposals submitted to the Center for funding are reviewed by the Research
and Graduate Programs Advisory Committee. The latter has one representative from
every department of the College of Veterinary Medicine and has been chaired by Dr.
Hildegard Schuller. Requests for 89 projects were funded during the reporting period
from 1995 to 2000. The following projects were supported this year by the Center:
CENTER OF EXCELLENCE PROPOSALS FUNDED IN

Name
Andrews, Frank
Brian, David
Cui, Mei-Zhen
Godkin, James
Mathew, Alan
McEntee, Michael
New, John
Oliver, Jack
Oliver, Steve
Rouse, Barry
Schuller, Hildegard
Schultz, Terry
Tithof, Patricia
Wang, Hwa-Chain

2000

Title ofProposal
Pathogenesis of acid injury in the non-glandular region of the equine stomach
Genetic structural elements regulating RNA synthesis during coronavirus
replication
Mechanisms oflipoprotein induction oftissue factor gene expression in smooth
muscle cells
Retinoids in oocyte maturation and embryonic development
Characterization of bacterial resistance elements in swine herds
Cellular mechanisms ofNSAID-mediated regression in intestinal tumors
A pilot project to survey rodent populations in the Great Smoky Mountains
National Park for the presence of hantavirus and Borrelia species
Studies oftall fescue toxin induced aminoacidemia in cattle
Identification and characterization of streptococcal virulence factors
Role ofchaperone bound peptides in the induction of antiviral CTL responses
Effects ofNNK on beta adrenergic growth regulation of pUlmonary
adenocarcinoma in vitro
Quantification ofthe underestimation of toxic potency in microscale testing
Effects of components of cigarette smoke on endothelial cell and vascular smooth
muscle cell arachidonic acid metabolism and apoptosis
Novel intracellular signaling pathways leading to cell quiescence and apoptosis

Additionally, COE funds were distributed to Drs. Xuemin Xu and Hwa Chain Wang as
part ofa "start-up" package approved during recruitment of these investigators.
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Equipment and Facilities
Annually, proposals for equipment purchases are solicited from eligible faculty.
Criteria considered in the allocation of these funds included justification of need,
equipment availability in adjacent laboratories, and the number of investigators who may
benefit. The latter is of particular importance; i.e. whether these pieces of equipment
could be used in a "core" role benefiting as many researchers as possible. Sixty eight
requests for purchase or upgrade of 98 pieces of equipment were either fully or partially
funded by the Center over the reporting period.
Requests from 14 investigators for 18 pieces of equipment were funded by the Center of
Excellence this past year. Researchers benefiting from the Center grants were Drs. Henry
S. Adair, Joseph Bartges, David Brian, Dennis Geiser, James Godkin, Alan Mathew, Jack
Oliver, Stephen Oliver, Barry Rouse, Hildegard Schuller, Terry Schultz, Carla
Sommardahl and Hwa-Chain Wang.
Renovations funded by the Center of Excellence over the past five years included
extensive repair and renovation of walk-in coolers in A329A and A307, laboratories in
the Veterinary Teaching Hospital. These coolers are used primarily by investigators
participating in the COE. Venting problems with class II type B2 and class II type A
hoods in A307A laboratory and in the P3 biosecurity facility required extensive
remodeling and certification. Similarly, repair and maintenance of several pieces of
research equipment was supported by COE funds. This included an ultracentrifuge and
the transmission electron microscope. The Johnson Biotechnology Animal Science
facility was completed and provides state-of-the-art laboratories and animal holding
facilities for some of our investigators. This facility includes two large laboratory animal
rooms and a student teaching area and consequently some space has become available in
the Veterinary Teaching Hospital for research activities. An addition to the College of
Veterinary Medicine also was completed during this reporting period. It houses the
Office of Laboratory Animal Care and supporting staff. These activities impact the
research program and occupation of these facilities has provided relief for housing
students and post -doctoral fellows in space previously occupied by this office.
With support from the Center of Excellence, Dr. Hildegard Schuller and other
COE participants in 1999 secured a substantial equipment grant from NIH. This grant
supported the purchase of a Facscan-Cell Sorter which will be used for basic and clinical
research. Matching funds provided by the Center was critical in the success of this
application. It will greatly enhance the research capacity ofthe Center.
Research Training
The College of Veterinary Medicine funds at least 10 positions for Ph.D. training
of students with a professional medical degree. Some of these positions are based in the
Department of Pathology (as part of their residencylPh.D. program) and some are
awarded without restriction. Most of these students become linked with Center of
Excellence faculty. These young investigators significantly bolster the achievements of
the Center. Center faculty that have benefited from these graduate students include Drs.
Brian, Tithof, Rouse, Schuller, Hahn, Wilkinson, and Wang. The Center has also
provided direct support for graduate students through proposals funded in the annual
competition.
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In addition, The University of Tennessee's College of Veterinary Medicine is one
of the few colleges of veterinary medicine to be chosen as a site for a National Institutes
of Health Institutional Training grant. This five-year training grant on the "Molecular
and Cellular Pathobiology of Environmental Disease" is funded through the National
Institute of Environmental Health Sciences. The grant began in 1995 and is funded
through the year 2000; past year expenditures were $218,931. This training grant is
centered in the Department of Pathology, but also involves scientists from other
departments as well as important collaborators in the Life Sciences Division at the Oak
Ridge National Laboratory. Dr. David o. Slauson has been Program Director for the
grant and Pathology Department Head. The research training sponsored by this NIH
grant emphasizes the basic molecular and cellular biology of disease, including
environmental disease. The existence of the Center of Excellence in the College was a
crucial element in the consideration by NIH for this award. Three DVM graduate
students were supported last year by these NIH funds and worked in the laboratories of
COE-associated scientists. They are Drs. Brian Jull, Steven Grubbs and Sharon
Witonsky. A total of 11 students have benefited from the program over the last five
years .
Student Awards
An important mechanism by which the Center of Excellence promotes biomedical
research is to provide summer opportunities for veterinary students to do investigational
work in research laboratories in the College of Veterinary Medicine. This past year the
Center funded eight requests from first- and second-year students. The students are
required to provide a summary of their work, which then is entered into a competition
judged by Phi Zeta, the veterinary honorary society. This program is very successful.
Several students presented their work to faculty and staff of the Institute of Agriculture
(see "Culture for Discovery") and at national scientific meetings. Numerous manuscripts
detailing results of work done by these students have been submitted for publication to
journals. In foeL over the past five years, tbis program has resulted in
approximately 30 publications in refereed journals, several with the students as
senior authors.
C.i-C""':>An

Personnel Changes
Dr. G. Michael Shires, Dean and Director of the Center of Excellence in
Livestock Diseases and Human Health retired at the end of the 1999-2000 fiscal year .
The new Dean of the College of Veterinary Medicine, Dr. Michael Blackwell, will serve
as the new Director of the Center. Because the Dean of the College of Veterinary
Medicine has announced the intention of adding an Associate Dean for Research to his
administration team, the Assistant Director of the Center likely also will be replaced in
2001. This will represent complete new management ofthe Center.
Unfortunately, several productive Center participants either retired or resigned
during this reporting period, especially from 1995 through 1998. They include Drs. Ted
McDonald, Walter Farkas, Mark Miller, Kevin Hahn, Linda Munson, Joyce Merryman
and Eric Schultz. Several of these were core members of the Center (McDonald, Farkas,
Miller and Hahn).
These personnel actions affected our benchmarks, especially
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extramural funding levels. However, recent strategic hires have significantly improved
the funding status ofthe Center.
Recent recruitments of faculty with a significant research focus will benefit the
Center of Excellence (see discussion on "Funding Levels"). Over the past approximately
two years we have recruited seven new researchers who will or are contributing to our
Center of Excellence. They include Dr. Hwa Chain Wang (Comparative Medicine
Department) who is well funded by NIH and Dr. Patricia Tithoff (Animal Science) who
has received very competitive scores for her proposals and likely will be funded by NIH
in the future. Dr. Joseph W. Bartges (Department of Small Animal Clinical Sciences) has
received substantial funding from a variety of industry sources and the Morris Animal
Foundation. Dr. David Slauson, head of the Department of Pathology in 1999, was able
to recruit Drs. Xuemin Xu and Mei-Zhen Cui. They brought with them significant
research funding from NIH (RO 1 grants), American Heart Association and foundations.
Their research interests also fall within the Center's focus. Dr. Robert Moore, head of the
Department of Microbiology, announced the recruitment of Dr. Pam Small from NIH, a
well-known expert on tuberculosis. She joined the faculty in October 2000 and plans to
do much of her research in the biosafety level three core facility in the veterinary
teaching hospital. Tuberculosis is again an emerging disease and Dr. Small's recently
received word of substantial funding from NIH to study this organism. Recently, Dr.
Hildegard Schuller, Interim Head of the Department of Pathology, announced the
approval of a search for an established researcher who would participate in the Center of
Excellence of Livestock Diseases and Human Health.
Drs. Dorcas Schaeffer (O'Rourke) and Monica Fann were recruited in 1998 and
2000 to fill the positions of Director and Associate Director of the Office of Laboratory
Animal Care respectively. This should have a significant impact in facilitating research
at the College of Veterinary Medicine.

out of extramural grants during the reporting period 1995 - 2000
was approximately $11,400,000.00 compared to the States investment of $2,669,910.00
over this period. Extramural support for the Center of Excellence increased dramatically
the last year of this five-year period. Retirements and resignations affected its growth for
the first two to three years of this five-year period. Therefore funding for the first three
years of this reporting period was steady and even declining slightly, but expenditures the
past year are the highest ever, surpassing by about $300,000 the amount in 1990-91, the
previous record. Our investment in recruitment of researchers the past two to three years
now is coming to fruition (see "Personnel Changes"). The State's investment in the
Center of Excellence in Livestock Diseases and Human Health remains a healthy one.
Extramural funding expenditures this year totaled $3,103,004 whereas the total funding
level of all active grants and contracts supporting the Center amounted to $11,946,613.
The rate ofreturn of State dollars for the year was 5.95!
Our investigators brought in $2,674,287 of new extramural funds in the past fiscal
year (Drs. Godkin, Mathew, McEntee, S.Oliver, Rouse and Schuller - see table 2). Also,
I am very encouraged that since the end of the 99-00 fiscal year, several COE faculty
appear to have secured new mUlti-year funding for COE-related research amounting to
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approximately $2,605,000. They include Drs. Barry T. Rouse, Michael McEntee and
Sharon Patton.
Dr. Schuller and co-workers recently received word that NIH is planning a site
visit early in 2001 as the first step of what we hope to be a positive evaluation of a
$12,000,000.00 Program Project (POI) on "Targeting Cell Type-Specific Regulatory
Pathways for Lung Cancer Intervention." This is a very encouraging development and it
must be noted that the Center has had a role in supporting Dr. Schuller's research for
several years now.
In fact the Center's emphasis on Molecular Genetics and
Carcinogenesis undoubtedly helped set the stage for developing this proposal. Likewise,
the Center has also supported Dr. Rouse's program. Dr. Rouse received word recently of
funding of a third ROI NIH grant. Total funding for his research (all years) is
$4,598,864. He appears to be the best-funded researcher (at least with respect to NIH
funds) at the University of Tennessee.
Culture for Discovery

In the past, the Center promoted a "Research Day" to showcase the achievements
of participating faculty and to promote research at the College of Veterinary Medicine.
Attendance at this event has declined significantly in recent years. It appears that the
format of scheduling an entire day or two for this event was not appropriate for local
participation. The past two years the Center has sponsored regular seminars, posters and
presentations by participating investigators and students. The program was advertised
University-wide and has been very well attended and received. It seeks to foster interest
in research and to display the Center's role in promoting research at the Institute of
Agriculture .
The College hosted at least 78 visiting research scholars during the reporting
period. They were supported by a variety of mechanisms including Center of Excellence
funds, the College's "Biomedical Seminar Series" and other funds. These scholars were
selected, in part, to contribute to the Center's research emphasis.
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VIRAL IMMUNOLOGY LABORATORY

Dr. Barry T. Rouse
Fellows, Staff and Graduate Students: S. Chun, S. De shpande , S. Kug Eo, U.
Kumaraguru, S. Lee, T. Sobhani, M. Zheng
Dr. Rouse's research deals with the recognition and interaction of the body with
viral infections. This group has studied herpes simplex virus, an agent that affects the
majority of humans. The virus persists indefinitely in infected individuals, and some
suffer periodic lesions which are painful and inconvenient. When such lesions occur in
the eye, they can lead to blindness. Dr. Rouse's laboratory is involved in studies directed
to understand the mechanisms by which herpes simplex infection causes blindness.
Dr. Rouse's approach to understanding the interaction between herpes simplex
virus and the immune system is to exploit model infections such as the mouse system as
an animal model. Their aim is to understand how cells and molecular events set into play
by herpes simplex virus lead to chronic inflammatory lesions or to resolution of disease.
Ultimately, it may prove possible to manipulate the host defenses either to achieve
protection by vaccines or resolution of injury by substances introduced by gene transfer
technology and capable of influencing the immune response.
In the last year they have used mouse models which have been genetically
manipulated to cause deficient immune systems and thereby to evaluate whether the
ocular lesions are the consequence of an autoinflammatory (self-destructive) reaction.
Their results do not support the latter hypothesis. Instead the evidence indicates that
herpes simplex replication in the eye causes the output of molecules called cytokines and
chemokines which activate certain invading cells of the immune system (T lymphocytes)
to release inflammatory substances. This mechanism is referred to as bystander
activation. Such a mechanism could represent an important component of any chronic
inflammatory reaction.
The other major activity in Dr. Rouse's laboratory is to understand the cell and
molecular events that occur during an immune response to novel DNA vaccines. They
have identified that a process called "cross priming" is the main event in this process and
that it is mediated by a "chaperone molecule" bound to a protein (peptide). They are
exploring the use of chaperone-bound peptides as a unique means of vaccination. This
could have a major impact in the prevention of viral diseases in people and animals.
The Center of Excellence supports some aspects of this research which is funded
primarily by substantial grants from the National Institutes of Health. Their work has
generated national and international interest, and the laboratory is recognized as one of
the premier viral immunology programs in the country. Dr. Rouse is one of a very select
group ofinvestigators in this country holding three ROt NIH awards simultaneously.
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MASTITIS RESEARCH LABORATORY
Dr. Stephen P. Oliver.
Fellows and Staff: R Almeida, W. Fang, B. Gillespie, M. Lewis, D. Luther, S. Ivey, L.
Coleman.
Research conducted by Dr. Oliver focuses on mastitis in daity cows caused by
environmental organisms. Several kinds of bacteria are capable of infecting the udder
causing mastitis. These pathogens invade the udder, multiply there and produce hannful
substances that result in inflammation, reduced milk production and altered milk quality.
Control of mastitis is extremely difficuh because of the many types and sources of mastitis
pathogens that can cause the disease. The National Mastitis Council estimates that mastitis
costs U.S. daity producers over two billion dollars annually. In Tennessee, losses due to
mastitis may exceed $25 million annually. Thus, mastitis in daity cows is likely the most
costly disease affecting daity producers in Tennessee, the U.S., and throughout the world .

Dr. Oliver was the first to show that mastitis in pregnant daity heifers occurred
frequently near calving and that many of these infections persisted into early lactation. His
research has resuhed in a simple, effective and inexpensive method for controlling mastitis
in heifers. Intra-mannnary antibiotic infusion before calving, was shown to be an
effective procedure for:
1) eliminating many infections in heifers during late gestation
2) reducing the prevalence ofmastitis in heifers during early lactation
3) for reducing the prevalence of mastitis in heifers throughout lactation.
He documented that a return of $12-$20 for each dollar spent was possible using this
approach.
Several studies over the past 13 years at the UT Dairy Experiment Station involved
collection of almost 200,000 milk samples for microbiological evaluation at intervals before
calving, during lactation and during the dry period. Data from those studies have been
computerized and this mastitis database may be the largest in the world. It now is being
exploited for retrospective studies and will provide valuable infonnation on the spread of
mastitis pathogens, such as Streptococcus uberis and Streptococcus dysgalactiae, in high
producing daity herds. Recently, they evaluated the influence of mastitis on reproduction in
Jersey cows and found it profoundly impairs reproduction during early lactation.

Dr. Oliver has been actively seeking the identification of virulence (severity) factors
produced by certain mastitis organisms (Streptococcus species) and implications of
immunity to them In many daity herds Streptococcus uberis and Streptococcus
dysgalactiae are responsible for a high proportion of mastitis with varying degrees of
severity in lactating and non-lactating daity cows. Strategies for controlling these mastitis
pathogens are poorly defined and inadequate. This research focuses on:
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1) genetic characterization of Streptococcus uberis and Streptococcus dysgalactiae
2) characterization of Streptococcus uberis and Streptococcus dysgalactiae with
particular emphasis on factors involved in adherence and invasion into
mammary epithelial cells
3) evaluation of immunity after immunization of dairy cows with components of
Streptococcus uberis and Streptococcus dysgalactiae
4) effectiveness of experimental vaccines to Streptococcus uberis and Streptococcus
dysgalactiae mastitis during the nonlactating period
Dr. Oliver's research group has detennined that Streptococcus uberis and
Streptococcus dysgalactiae readily adhered to and invaded cells lining the bovine udder.
Chronic infections then may develop, and their intracellular location may protect these
bacteria from anti-microbial drugs and host defense mechanisms. Mastitis pathogens
cultured in the presence of mammary epithelial (lining) cells in the laboratory synthesize
proteins not detected when bacteria are cultured alone. These unique proteins likely are
involved in virulence of bacteria, including their capacity to adhere and invade mammary
epithelial cells. Thus, culture of mastitis pathogens in the laboratory in the presence of
mammary epithelial cells may result in expression of bacterial virulence factors similar to
that which occurs in the animal. This important discovery will be exploited for the
development ofvaccines and management ofmastitis.

Dr. Oliver's expertise in mastitis and milk quality has led also to a new research
initiative in food safety. The primary goal is to provide comprehensive information on the
occurrence and distribution of Salmonella, Escherichia coli 0157:H7, and Campylobacter
jejuni in bulk tank milk, feces of cull dairy cows and the environment in dairies. Antibiotic
resistance patterns and molecular characterization of foodbome pathogens is also being
done .

Dr. Oliver has corrnnunicated results of his research via scientific and popular press
publications, and via presentations to several different target groups at state, regional,
national and international meetings and conferences. In addition, Dr. Oliver has made
several presentations to groups such as the University of Tennessee Agricultural Committee
Board of Trustees, the Institute of Agricuhure Development Board and the 21 st Century
Campaign Steering Committee and Tennessee Agricultural Experiment Station Department
Dr. Oliver has given presentations entitled ''The University of
Heads' Conference.
Tennessee Mastitis Research Program: Making a Difference Through Research" to the
Tennessee House of Representativies Agriculture Committee, to The University of
Tennessee Institute of Agriculture Alumni Council and to the University of Tennessee
Institute of Agriculture Development Board and Agriculture Steering Committee for the 21 st
Century Campaign.
Dr. Oliver has increased the awareness of scientists, extension specialists, dairy
producers and pharmaceutical companies of the importance of environmental pathogens in
bovine mastitis. Furthermore, he has discovered fundamentally important infonnation that is
critical for controlling the heterogeneous organisms that cause mastitis. Dr. Oliver's
research philosophy is to design and conduct innovative and useful studies and to report to a
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wide variety of constituents. The ultimate goal of this research is to enable dairy producers
in Tennessee, the U.S., and throughout the world to enhance the quantity and quality ofmilk
produced and thus reduce the economic impact of mastitis.

Dr. Oliver's research has been supported for several years by the Center of
Excellence, but his primary funding has been derived from substantial grants from
foundations, FDA and the pharmaceutical industry.

VIRUS MOLECULAR BIOLOGY LABORATORY
Dr. David A Bnan
Fellows and Graduate Students: Dr. S. Senanayake, Dr. K. Nixon, Dr. A. Ozdarendelli,
G.D. Williams, S. Raman, C. Gay, H. Wu.
Dr. Brian's interest in basic molecular biology of viruses has resulted in
discoveries of a fundamental nature for which his laboratory has received national and
international recognition. His research focuses on coronaviruses which cause of some of
the most costly respiratory and gastroenteric diseases of livestock and fowl, and disabling
diseases of people. Efforts to control coronavirus infections have been frustrated by three
major obstacles:

1.

2.
3.

An incomplete understanding of how coronaviruses replicate and persist in
animals.
The ability of coronaviruses to rapidly mutate into new pathogenic
variants.
The generally weak immune responses in animals to coronavirus
vaccination and the logistical problem of inducing protective mucosal
(local) immunity in the vulnerable newborn.

The primary research focus in Dr. Brian's laboratory is the molecular biology of
coronavirus replication. With funding from the USDA and the NIH, and modest support
from the Center of Excellence, they are making an intense effort to understand how five
separate genetic elements in the coronavirus function to regulate production of viral
proteins and progeny virus. Research is being done also on a sixth genetic region, a hot
spot for variability, in an effort to understand the determinants of this process. Genetic
recombination (blending) at this site is a mandatory step used by the virus in the
generation of messenger molecules that encode portions of the virus' genetic material. It
is anticipated that information from these studies will significantly impact the design of
new therapeutic strategies.
Of special interest is how a newly discovered element at one end of the virus gene
regulates replication of the genetic material. The element is a tRNA-like folded structure
(a pseudoknot), that may regulate virus replication by incorporating a cellular protein in
the virus replication machinery.
Therapeutic interruption of such a virus-protein
interaction may lead to a cure of virus infection. Interestingly, one candidate protein in
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this interaction is histidyl tRNA synthetase, a factor (auto antigen) in the human disease
polymyositis.
Dr. Brian's laboratory has also discovered a small genetic variant of the bovine
coronavirus (a viral minigenome) that replicates in the presence of "normal" virus. This
minigenome is being experimentally engineered to carry many kinds of potential antiviral
molecules into cells. One molecule is an enzyme (a ribozyme) designed to destroy the
gene on which the virus depends for replication (the polymerase gene). This novel
therapeutic approach would, in theory, cure a virus-infected cell without killing it .

ANTmIOTIC RESISTANCE LABORATORY

...

Dr. Alan G. Mathew
Staff and graduate students: R. Clift, S. Chattin, D. Arnett, P. Cullen, P. Ebner, K.

Garner, G. Pulliam
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Antimicrobial compounds are commonly used in US livestock systems.
Therapeutic use of antibiotics continues to play a major role in combating disease
organisms, while subtherapeutic use in feeds increases animal performance, decreases the
numbers of infectious organisms in the environment, and lowers the prevalence of
organisms causing foodbome illness in humans.
In contrast to the above benefits, some evidence suggests that agricultural use of
antibiotics may be partly responsible for the emergence of drug-resistant bacteria, which
in tum may decrease the efficacy of similar products used in human medicine. However,
little information is available on strategies for controlling of antibiotic-resistant
organisms. In particular, almost no information is available with respect to modem
livestock production facilities, management, environmental conditions, or drug therapies
that affect resistance in organisms. Because resistance may be transferred to bacteria
from a variety of resistant bacteria and associated hosts, it is important that factors
involved are characterized so that more e:trective control strategies can be formulated .
A primary research focus of Dr. Mathew's group is to characterize genetic factors
that lead to antibiotic resistance in animal and human pathogens. They also are
investigating how different uses of antibiotics in livestock production affect antibiotic
resistance patterns, concentrations, and shedding of foodbome pathogens. They hope to
determine the most effective antibiotic therapies and husbandry practices to maintain
animal health, while at the same time limiting prevalence of foodbome pathogens and
antibiotic resistance ofmicroorganisms in livestock.
Recent work by the group has included a pioneering microbiological survey of
swine farms that used or excluded antibiotics in the animals. They determined that
pathogenic bacteria from farms that excluded antibiotics were more sensitive to
antibiotics. However, resistant isolates occurred on both farm types, and young, recently
weaned animals from all farms harbored the greatest number of resistant isolates. This
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may indicate that stresses associated with weaning affect bacterial antibiotic resistance
patterns, regardless of whether antibiotics were used on the farm.
Dr. Mathew investigated also the effects of antibiotic treatment regimens on
resistance patterns of E. coli and Salmonella bacteria in pigs. They inoculated pigs with a
swine pathogen (K88 E. coli) and a foodbome pathogen (Salmonella typhimurium) and
then treated with aminoglycoside, sulfonamide, and beta lactam antibiotics using various
dosing schemes. Dosage methods, dosage levels and rotation with dissimilar antibiotics
affected the genesis of resistance.
Another important discovery was that E. coli associated with livestock became
resistant much more quickly than Salmonella in the same host, possibly indicating a
greater ability to acquire resistance elements such as plasmids (R-factors), or a greater
ability to generate chromosomal resistance elements. This finding will be very important
as we assess the agricultural use of antibiotics and the risks of generating resistance in
foodbome pathogens. They now are characterizing the bacterial resistance elements
using various DNA-based techniques to determine the relative importance of R-plasmids
and chromosomal elements in the acquisition and persistence of antibiotic resistance.
Dr. Mathew is continuing other work to determine how animal stressors such as
crowding, low sanitation, and temperature stress affect the prevalence of antibiotic
resistance in Salmonella typhimurium and E. coli in swine. Preliminary data indicate that
such stressors increase the percentage of resistant isolates.
Work with Dr. Stephen Oliver has focused on the development of rapid methods
for detection and differentiation of Salmonella variants. This will allow us to determine
the origin and reservoirs of those bacterial variants that are most responsible for
foodbome illness in livestock operations. They have determined that a linked PCR
ELISA assay is capable of rapid (less than 24 hours) differentiation of Salmonella
bacteria from livestock samples.
Such techniques will be instrumental in the
implementation of on-farm Hazard Analysis Critical Control Points (HACCP) strategies
for management of specific foodbome pathogens.
Dr. Mathew's research is supported by the Center of Excellence but primary
funding for this work is derived from the International Life Science Institute and the
National Pork Producers Council.

BIOPHYSIOLOGICAL PATHOGENESIS LABORATORY

Patricia K. Ti'thof
Collaborators, Staff and Graduate students: Dr. M. Peters-Golden, Dr. H. Schuller, Dr.
H.C. Wang, Dr. R. Donnell, M. Elgayyar, M.A. Barnhill
Dr. Tithofs research program in cardiovascular physiology concerns the effects
of specific components of cigarette smoke on the biology of blood vessel lining
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(endothelial) cells and metabolism of a potent physiological chemical messenger,
arachidonic acid. The latter is a fatty acid that is present in high quantities in the
membranes of all cells and is a substrate for the production of eicosanoids, a family of
biologically active lipid mediators. The latter have an important role in several diseases
including asthma, arthritis, cancer and atherosclerosis .
Smoking, which greatly augments the process of atherosclerosis, increases the
risk for heart attack or stroke by as much as 50%. Recent epidemiologic studies indicate
that a high fish diet or frequent use of aspirin significantly decreases mortality rates due
to heart attacks in heavy smokers. Fish contains high levels of certain fatty acids, which
decrease the availability of arachidonic acid and also inhibit the production of
arachidonic acid-derived eicosanoids. The protective effects of these fatty acids and
aspirin against smoking-induced atherosclerosis suggest that components of cigarette
smoke stimulate the arachidonic acid pathway_ However, no previous studies have
focused on the specific components of cigarette smoke responsible for this effect.
Several compounds are contained in high concentration within the tar fraction of cigarette
smoke. These include methylanthracenes, phenanthrene and benzo(a)pyrene.
Benzo(a)pyrene accelerates the development of atherosclerosis in animal models.

..

Endothelial cells form a single cell layer lining the blood vessel wall. Endothelial
cell death and loss is a critical and important event in the early development of
atherosclerosis. Loss of the endothelial cell layer results in inflammation of the vessel
wall, vasoconstriction and clot formation; events important in the development of heart
attacks and strokes. Previous studies indicate that cigarette smoking increases the rate of
endothelial cell loss; however, neither the mechanism of cell death nor the specific
components of cigarette smoke responsible have been elucidated .

..
..
..

These studies indicate that exposure of porcine aortic endothelial cells or human
coronary artery endothelial cells to these compounds in cigarette smoke causes release of
arachidonic acid. Furthermore, this release of arachidonic acid is associated with loss of
endothelial cell viability through stimulation of a process known as apoptosis or
programmed cell death. Apoptosis induced by these compounds can be inhibited by the
fatty acid, eicosapentaenoic acid, which exists at high concentrations in fish. These
results suggest that methylanthracenes, phenanthrene and benzo(a)pyrene may be
important components of cigarette smoke that augment atherosclerosis through a process
that involves arachidonic acid-mediated killing of endothelial cells.

..

Dr. Tithof also has initiated studies to investigate the effects of derivatives of
nicotine on endothelial cell function. A derivative of nicotine, NNK, plays an important
role in smoking-induced lung cancer. Recent studies in collaboration with Dr. Hildegard
Schuller suggest that NNK induces tumor formation by a mechanism that involves
release of arachidonic acid by stimulation of certain cell receptors (beta-adrenergic). The
finding that NNK binds to beta-adrenergic receptors has important implications
concerning a potential effect of NNK on the cardiovascular system. Evidence indicates a
role for the beta-adrenergic system in the cause of atherosclerosis because beta
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adrenergic blocking agents prevent endothelial cell injury Beta-adrenergic blockade also
reduces endothelial cell injury induced by cigarette smoke.
The effects ofNNK on endothelial cell viability were investigated by Dr. Tithofs
group. NNK, at very low concentrations caused apoptotic cell death of endothelial cells.
Their results suggest that it was the result of NNK binding to beta-adrenergic receptors
and that the arachidonic acid cascade was involved.
These studies provide novel findings concerning the effects of specific
components of cigarette smoke on endothelial cell function and suggest a novel
mechanism by which cigarette smoke augments atherosclerosis. These studies may
contribute to the development of effective measures for preventing cardiovascular
complications in smokers. Moreover, identifying specific components of cigarette smoke
that augment disease may lead to the development of safer cigarettes. These strategies
may be particularly important because the incidence of smoking continues to rise, despite
intensive efforts to educate people about the hazards of smoking .

REPRODUCTION LABORATORY
Dr. James D. Godkin
Fellows, Staff and Graduate Students: Dr. D. Eberhardt, T. Livingston, H. King, S.
MacKenzie, M. Roberts

The focus of Dr. Godkin's research group over the past few years has been the
study of proteins that communicate fetal-maternal interactions and result in the successful
maintenance of pregnancy. One important discovery was that interferon-tau, a placental
protein, interacts with the uterus and alters maternal hormonal balance and maintains
early pregnancy in ruminants such as cattle, sheep, goats, and buffalo. Another focus of
Dr. Godkin's laboratory is reproductive efficiency with respect to the effect of growth
factors and certain vitamin A-like proteins (retinoid-associated) and their genes on the
early embryo, ovary, oviduct and uterus.
The major current focus of Dr. Godkin's laboratory is on factors that control
development of the early embryo of domestic livestock. Recently, they made the
remarkable discovery that treatment of animals with vitamin A-like compounds
(retinoids), just prior to ovulation, results in improved viability of embryos that then
develop following fertilization. In addition, his laboratory studies indicated that
treatment of embryos with retinoids dramatically improved embryonic development. The
goals of this research are to improve reproductive efficiency through the use of retinoid
administration procedures, to develop more efficient assisted reproductive procedures and
to determine the mechanisms by which retinoids affect oocyte (egg) maturation,
embryonic development and survival.
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This research has the potential to improve reproductive efficiency in livestock and
improve assisted reproductive procedures in humans. It also has an application for the
preservation of endangered species.
A patent application has been filed covering the use of retinoids in assisted
reproductive procedures with the assistance of the UT Research Corporation. Dr.
Godkin's research has received support from the Center of Excellence which has been
leveraged into substantial funding from the USDA's National Research Initiative.

GASTRITIS PATHOGENESIS LABORATORY
Dr. Frank M. Andrews
Collaborators, staff and graduate students: Dr. A.G. Mathew, Dr. C.S. Patton, Dr. J.T .
Blackford, Dr. A.M. Saxton,. Dr. S. Murphy, Dr. 1. Collins, Dr. R. Torres-Diaz, M.
Sewell, A. Nadeau

Dr. Andrews studies the genesis and mechanisms of gastric ulcer development in
a horse model. Gastric ulcer disease is a common problem in performance horses. The
latter are commonly fed concentrated high-energy feeds that contain high levels of
carbohydrates (starches). These carbohydrates undergo fermentation by resident bacteria
in the stomach that may result in release of by-products such as volatile fatty acids
(acetic, butyric, valeric and propionic acids). Previous research in this laboratory
established that high concentrations of volatile fatty acids are produced in the stomach of
horses fed high-energy diets. These acids, due to their high lipid solubility, diffuse into
the non-glandular gastric cells causing acidification and damage to sodium transport,
which leads to cellular injury and gastric ulceration.
Current studies involve examination of fresh viable non-glandular tissue (most
susceptible to gastric ulceration) from the stomach of horses. Tissues are placed in an
Ussing chamber system, which allows measurement of tissue short-circuit current
(sodium flow) and resistance across the tissue. A decrease in short-circuit current and
resistance are the first indicators of tissue damage, and precede gastric ulcer formation.
These tissues then are viewed under the microscope after special staining to determine
the nature and extent of cellular damage.
Dr. Andrews' research suggests that volatile fatty acids, especially butyric and
propionic acids in contact with the stomach lining of horses and in the presence of
stomach acid (PH = 1.5 and 4.0) leads to damage to cell's sodium transport system,
cellular swelling, irreversible tissue damage and ulceration. These findings suggest that
dietary modification, reducing the formation of these acids, may be helpful in prevention
or decreasing the incidence of gastric ulcer disease in horses. These results have
implications for several animal species including humans.
This research is funded by the Grayson-Jockey Club Research Foundation, the
Comparative Gastroenterology Society and the Center of Excellence.
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TALL FESCUE TOXICITY LABORATORY
Dr. Jack W. Oliver
Co-investigators and staff:
Dr. R. Linnabary, Dr. E. Schultze and Dr. B. Rohrbach,
L.K. Abney, E.M. Bailey, M. Cottrell and J. Czarra
Tall fescue toxicosis continues to be the primary grass-related disease in the
United States in terms of economic loss to animal producers, affecting over 8.5 million
beef cows and 700,000 horses. Tall fescue toxicosis is also a costly disease to Tennessee
cattle producers, resulting in an approximate $100 million dollar annual loss due to
unrealized production. Tall fescue is an attractive forage species because of its ability to
withstand drought, poor soil conditions and intensive defoliation from grazing. It is
grown on more than 34 million acres of pasture, but 75% of the pastures are infected with
the endophytic-fungus, Neotyphodium coenophia/um, at a sixty percent or greater level.
Most ofthe infested pastures are in the Southeastern United States.
The endophyte-grass association results in the production of alkaloid toxins
produced by the fungus or by the plant in response to the fungus. The alkaloids are
biologically active causing a decrease in appetite and impaired reproduction and growth
in animals. Endophyte-infected tall fescue has greater forage and seed productivity than
the non-infected variety and is more drought tolerant. At the same time, tall fescue
toxicosis is a costly disease to animal producers, causing severe reductions in weight
gains, milk production and fertility.
Results of studies by Dr. Oliver's group have established that vascular damage is
a central event that occurs when herbivores consume infected tall fescue. As a
consequence of injury to blood vessels, blood flow to tissues is impaired causing
localized tissue damage and thereby affecting the function of body systems. The
abnormalities in blood flow are integrally related to the economic losses encountered by
the cattle industry in the United States. Dr. Oliver has been examining toxicity associated
with purified alkaloids that are suspected of being the primary tall fescue toxins (i.e.
ergine, ergovaline). The long range goal of these studies is to understand how the
individual toxic alkaloids cause damage to tissues of cattle because little is known
regarding which ofthe alkaloids in tall fescue cause(s) the lesions in this syndrome.
Studies have been completed on analyses of various parameters of blood and
tissues in steers that grazed endophyte-infected tall fescue over a three-year period.
Markedly suppressed levels of serum copper were recorded in consecutive years, and
copper deficiency may be the basis of the poor haircoats in these cattle. Gamma globulin
(antibody) levels these cattle also were significantly reduced, suggesting that
immunosuppression is an important aspect of the disease too. This information of tall
fescue toxicity in cattle will be important in evaluating anti-fescue toxicosis treatments.
Continued research will be focused on the chronic effects of the two important
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alkaloids of toxic tall fescue, ergine and ergovaline. Cattle will be treated with each of
these alkaloids to evaluate their effect on the function of a specific blood vessel receptor
(alpha-2 adrenergic). Dr. Oliver determined that ergo valine administration at the rate of
0.2 ug/kg/hour caused the typical decrease in the hormone (prolactin) in blood that occurs
in cattle grazing on fungus-infected tall fescue pastures. Since the lining cells of blood
vessels (endothelial cells) are danlaged by exposure to the alkaloids, several
inflannnatory mediators associated with endothelial cell injury will be measured in the
serum of the cattle that are infused with ergine or ergovaline.
Laboratory studies with isolated bovine endothelial cells or smooth muscle cells,
grown in culture were treated with various concentrations of ergovaline and ergine. Both
of these alkaloids are toxic to endothelial cells but ergo valine was considerably more
potent. Dr. Oliver's results indicate that manipulation of the infection allowing ergine
production in the plant but elimination of ergovaline presence would be beneficial. The
ergine is necessary to convey insect resistance to tall fescue and the toxic effect would be
minimized because the absence of ergovaline. Reducing the toxic effect of ergo valine in
cattle will allow increased use of tall fescue, a forage with excellent nutrient quality, and
root development that helps to control soil erosion. Dr. Oliver's research has been
supported by the Center of Excellence, but his primary support is from the USDA's
National Research Initiative.

...

BIOLOGICAL ACTIVITY TESTING AND MODELING LABORATORY

.

Dr. Terry W. Schultz
Staffand Graduate Students: G. Sinks, B. Gregory, J. Seward, and E. Hamblen

-..
-

Research in the Biological Activity Testing and Modeling Laboratory focuses on
developrr!ent of databases for structure-toxicity modeling and the development and
validation of such models. The values of structure-toxicity models lie in their ability to
predict toxic potency from molecular structure. This means that hazard assessment can
be done while conserving time, manpower, resources, and animals.
Toxic potency is related to the uptake of the toxicant from the environment and its
interaction with certain molecular sites of action. Since certain properties (such as
hydrophobic, electronic, and steric factors) are related to molecular structure, Dr.
Schultz's group focuses on identifYing global descriptors of such properties that are best
in modeling of uptake and interaction. Previous work by Dr. Schultz's group have shown
that the site of action for toxic events is the cell membrane. In the case of covalent
events, it is soft nuc1eophiles associated with membrane-bound proteins, whereas, in the
case ofnon-covalent events it is the fatty acids of the membrane lipid bilayer.
This past year Dr. Schultz and his students have examined the ability of different
molecular-orbital quantum-chemical parameters to quantify electrophilic reactivity. They
have developed quantifiable chemical measurements for different types of interactions or
bonding between the toxicant and its site of action.
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Most recent work has focused on chemicals whose toxicity does not model well
by this descriptor. Julie Seward, a senior doctoral student supported in part by COE
funding, has shown that certain aromatic chemicals follow a unique model.
Other work in Biological Activity Testing and Modeling Laboratory has extended
this approach to identify properties that best model toxic responses where interactions
occur between the conlpound and a specific cell receptor. In the past year, this work
focused on understanding the properties governing hormonal effects associated with the
human estrogen receptor. Through an examination of the estrogenic activity of a series
of selected chemicals using the Saccharomyces crevice-based lac-Z reporter assay, Dr.
Schultz and his colleague were able to characterize and quantify the potency of estrogens
that occur in the environment.

EXPERIMENTAL ONCOLOGY LABORATORY
Dr. Hildegard M. Schuller
Fellows, Staff and Graduate Students: Dr. H. K. Plummer III, Dr. Brian A. Jull, Dr. Y.
Cakir, N. Neilsen, and K. Walker
Lung cancer is the leading cause of cancer deaths in all industrialized countries.
East Tennessee has one of the highest lung cancer rates in the United States. Although
cancers at other organ sites are more than twice as common, their cure rate is
considerably higher. The most common cancer in men is prostate cancer, with a cure rate
of 84%. Breast cancer is the leading type ofcancer in women with a cure rate of74%. In
contrast, 158,700 (89.3%) of the 177,700 patients diagnosed with lung cancer in the year
1997 died within 12 months ofdiagnosis.
Smoking and exposure to second-hand smoke are the most intensively studied and
best-documented risk factors for the development of lung cancer. Contrary to cancers at
other organ sites, the incidence of lung cancer continues to rise in all industrialized
nations. Moreover, teen smoking in the U.S. has increased at an alarming rate, thus
setting the stage for even higher numbers of lung cancer cases 30-40 years from now.
Another important contributing factor to the rise in lung cancer cases is the growing
number of lung cancers developing in individuals never exposed to primary or second
hand smoke. This trend, which has been globally observed during the last two decades in
all industrialized countries, is particularly evident for pulmonary adenocarcinoma. Of the
six types of lung cancer recognized by the World Health Organization classification, two
(small-cell carcinoma and adenocarcinoma) accolmts for 90% of all lung cancers, but
30% of these cases do not have a history of exposure to primary or second hand smoke.
The lung cancer "epidemic" is closely related to a globally observed rise in
chronic lung diseases such as bronchitis, bronchiolitis, asthma, emphysema, and chronic
obstructive pulmonary disease. This disease complex, which is often referred to as
"allergies" has the same geographic distribution as lung cancer with which it shares some
risk factors such as smoking and air pollution. Accordingly, East Tennessee, which has
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one of the highest lung cancer rates in the U.S., is also often referred to as "the land of
allergies." For all lung cancer types, chronic lung disease has been identified as a risk
factor even without a history of exposure to smoke .
Dr. Schuller's research has been dedicated to the study of lung cancer for over 20
years. It is her belief that effective strategies for the prevention and therapy of this
disease complex can only be based on an in-depth understanding of the regulatory
mechanisms which govern the growth of normal lung cells and the cancers arising from
such cells. In contrast to other laboratories that are searching for the "magic molecular
event" responsible for the genesis of all lung cancers, she hypothesized that different lung
cell types and different types of lung cancer may be governed by different regulatory
mechanisms, which in turn may be affected differently by known risk factors for the
disease.
Dr. Schuller's achievements in lung cancer research have been recognized
nationally and internationally. Her research has been supported by the Center of
Excellence, but her primary support comes from substantial grants of the National Cancer
Institute and the pharmaceutical industry.
Dr. Schuller's group previously determined that the growth of small cell lung
carcinoma and the cell of origin of this cancer type (pulmonary neuroendocrine cell) is
regulated by a specific cell surface receptor (nicotinic acetylcholine) which has an
important biochemical function (calcium channel). She found also that the tobacco
specific carcinogenic product (NNK) activates this receptor with high affinity. Binding
of this product to the receptor causes a release of a biochemically active substance
(serotonin) by these cells and that this substance markedly stimulates cell division when
it is taken up by other cells. This is an important finding because it links, for the first
time, the stimulation of a specific receptor by a tobacco-specific toxicant resulting in the
activatiorJ. of a series of cell-specific events that may result in uncontrolled growth.
Experiments are now underway to test the hypothesis that substances which inhibit the
re-uptake of serotonin will protect against the development and spread of small cell lung
carcinoma. These drugs are already approved for the treatment of psychiatric diseases
and migraine and could immediately enter clinical trials in smokers and small cell
carcinoma patients.
Laboratory studies with various cultures of small cell lung cancer cells and
pulmonary neuroendocrine cells suggest that smoking or chronic exposure to the product
NN~ increases the concentration of the target receptors on these cells. Dr. Schuller now
is working with Dr. Kabalka of the Department of Chemistry on the development of
novel cancer imaging agents which selectively bind with high affinity to this receptor that
will allow for a selective and highly sensitive detection of small cell carcinomas in people
(by positron emission tomography). This will constitute an important clinical application
of her research. The Center's emphasis on Molecular Genetics and Carcinogenesis and
Dr. Schuller's work and collaboration with various investigators has culminated in a
Program Grant Proposal to NIH for $12,000,000.00 (see section on "Research Funding").

21

..

-..
..

.
..
..

-..
-

..

-

..

-

-

..

-

...

..

ANTICANCER MOLECULAR ONCOLOGY LABORATORY

Dr. Hwa-Chain R. Wang
Fellows: K. Fecteau, 1. Mei, Y. Sun, M. Tan
Dr. Wang's long-term research goals concerns tumor-specific intracellular
molecular signaling networks and to uncover signaling pathways that can be induced by
anticancer agents to lead cancerous cells into programmed cell death (apoptosis) .
Short-term goals are to identifY intracellular signaling elements whose activation
is involved in induction of apoptosis or growth inhibition of cancer cells. A corollary to
this is to identifY novel anticancer agents, which may selectively induce apoptosis of
cancer cells while sparing normal cells.
Ultimately, he expects to apply the
understanding of intracellular signaling control to anticancer therapeutics and prevention.
Currently, Dr. Wang focuses on three projects. The first is to understand the
molecular and cellular function of a family of novel intracellular enzymes (Krs and QIK),
which are induced in resting cells and cells undergoing programmed cell death. The
second is to study molecular and biological activities of a novel natural anticancer agent
(FR901228), which selectively induces programmed cell death of cancer cells. The third
is to study the molecular and biological roles of mutations in genes that control tumors
(suppressor genes - transforming growth factor beta receptor genes, Tf3R-II and Tf3R-I) in
the development ofhuman oral cancers.
Dr. Wang has identified a family of novel enzymes (kinases: SAMKIKrs1 and QIK) that
are activated in normal resting cells and in cancerous cells undergoing programmed cell
death (as a result of a variety of physiological, chemical or physical stresses). Induction
of QIK activity is involved in establishing cell quiescence but additional activation may
result in cell death. He is investigating the molecular and biological roles of these
enzymes in cancer development and programmed cell death. Uncovering the apparent
novel signaling pathway that cross-links cancer development of cells to programmed cell
death should be directly exploitable for development of anticancer therapeutics.
Investigation into the molecular mechanisms of potential anticancer therapeutic
agents on a variety of cancer cell types particularly human breast cancer cells is ongoing.
Cancerous mouse embryo cell cultures and various human tumor cell cultures are used to
screen anticancer agents. Studies on the molecular effects of a novel natural anticancer
agent (FR901228) on different intracellular metabolic signaling pathways should uncover
the mechanism of this agent to selectively induce programmed cell death in cancerous
cells. Dr. Wang determined that at least five important intracellular metabolic signaling
pathways including the QIK pathway are affected. The information will be a basis for
clinical trials using FR90 1228 in combination with other anticancer agents.
The role of mutations in tumor suppressor genes (Tf3R-II and Tf3R-I genes) in the
multi-stage development of human oral cancers will require the detection and analysis of
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the mutations in these genes isolated from pre-malignant and malignant cells of the oral
cavity. Specific mutations in the Tf3R-II and Tf3R-I genes will be identified by their
functional inability to transmit signals to suppress tumor formation. This research is a
part of a major collaborative program project to study molecular events in progression
and prevention of oral cancer.
Dr. Wang's research is supported by the Center of Excellence, but his primary
funding source is the National Institutes of Health (National Cancer Institute and National
Institute ofDental Research) .

CANCER MODELLING LABORATORY
Dr. Michael McEntee
Collaborators, Staff and Graduate Students: Dr. 1. Whelan, A. Cruikshank, N. Neilsen
Dr. McEntee's research focuses on defining the relationship between tissue levels
of polyunsaturated fatty acids, their metabolism as bioactive lipids (such as prostaglandin
E2), and forms of cancer to which they have been linked. In collaboration with a
biochemist in the Department of Nutrition at UT, Dr. 1. Whelan, he demonstrated
recently that specific dietary polyunsaturated fatty acids can significantly protect against
the development of intestinal cancer in a mouse model of the human disease. Non
steroidal anti-inflammatory drugs like aspirin inhibit the metabolism of polyunsaturated
fatty acids into various prostaglandins. Their research involved the simultaneous
pharmacologic and dietary manipulation of tissue polyunsaturated fatty acids
concentrations.
Polyunsaturated fatty acids derived from fish oils reduced the incidence of this
of neoplasia by 50% in comparison to polyunsaturated fatty acids common in the
U. S. diet (i.e. animal fat and vegetable oil). Their research suggested that this protective
effect was specifically attributed to longer chain, highly unsaturated polyunsaturated fatty
acids. Dr. McEntee also demonstrated for the first time in an animal that prostaglandins
produced from the "bad" tissue polyunsaturated fatty acids specifically contributes to
intestinal tumor growth. Inhibition of the metabolism of polyunsaturated fatty acids
found in com oil and red meat to prostaglandins significantly contributes to intestinal
carcinogenesis.
The importance of prostaglandins in production of tumors was subsequently
confirmed in experiments where tumors were eliminated following treatment with an
antibody that specifically inactivates this po lyunsaturated fatty acid product.
Prostaglandin E2 acts through specific cell receptors and they have shown that it is
produced by the non..neoplastic part of intestinal tumors of their mouse model (as it is in
humans).
They are currently attempting to characterize the distribution of the
prostaglandin Ez receptors in these lesions in order to better understand the link between
the production/target activity of this specific bioactive lipid and intestinal carcinogenesis.
Recent data suggest that the molecular changes contributing to intestinal carcinogenesis
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in humans and their mouse model also occur in pet dogs that develop this fonn of
neoplasia. This strongly implies that the beneficial effects of dietary and pharmacologic
intervention demonstrated in the mouse model would directly translate to dogs, as well as
humans.
In addition to the above experiments, studies have been initiated to investigate the
contribution of polyunsaturated fatty acids and their metabolites to another common fonn
of neoplasia that has been strongly linked to dietary fats in humans, prostatic cancer.
Dr. McEntee receives support from the Center of Excellence, but his primary
funding is derived from the Department of Defense, American Institute of Cancer
Research and Monsanto.

CELL BIOLOGY LABORATORY

Dr. Xuemin Xu
Staff and Graduate students: G. Mao, Ph.D., Y. Shi, W. Gao, and E. Laag
The long-term goal of Dr. Xu's research is to understand the molecular and cellular
mechanism of Alzheimer's disease, a'nd the formation of senile plaques, the pathological
hallmark of this disease. His group is conducting two projects. One is to detennine the
pathological function of a substance (presenilin 1) in brain degeneration and the genesis of another
substance (amyloid) observed in Alzheimer's disease. The other project is to detennine the role ofa
certain protein (apolipoprotein E) in the formation and clearance of another protein involved
Alzheimer's disease (J3-amyloid peptide).
Alzheimer's disease is a progressive degenerative disorder, characterized by memory loss,
confusion, and a variety of cognitive disabilities. An estimated four million American suffer from
Alzheimer';s disease. It is the fowth rnajoI cause of death in the United States following heart
disease, cancer, and stroke. Alzheimer's disease is the third most costly disease in the U.S. With
the rapid growth of the senior population, Alzheimer's disease poses, besides its tragic personal
impact, serious problems to families, caregivers, government and health care in institutions.
Molecular genetic analysis of familial (heritable) Alzheimer's disease has led to the
identification of three Alzheimer's disease-causative genes, those of J3-amyloid precursor protein,
presenilin 1, and presenilin-2. A fourth gene encoding apolipoprotein E has also been associated
with Alzheimer's disease as a risk factor but not as a causative gene for Alzheimer's disease.
Among these Alzheimer's disease -causative genes, mutations in presenilin 1 gene account for the
majority of the known cases of familial Alzheimer's disease. Presenilin 1 has been implicated in
two pathological events: (1) the generation ofamyloid-J3 peptide, which is the building block ofthe
toxic "plaques" characteristic of brain tissue from patients with Alzheimer's disease, and (2)
programmed cell death, or apoptosis, a natural process in which unneeded or worn-out cells
commit suicide. However, questions regarding the mechanisms by which the mutations in
presenilin 1 proteins alter J3-amyloid precursor protein processing and cause programmed cell
death, as well as the normal function of presenilin 1, remain to be answered, which is the goal of
their current research project.
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Recent work resulted in the identification of a novel molecule (PSAP) which is capable of
inducing progrannned cell death, one of the mechanisms of neuronal cell death observed in
Alzheinler's disease brains. It reacts specifically with presenelin 1. This finding established for the
first time the molecular link between presenelin 1 and progrannned cell death. Currently, we are
conducting the experiments to determine the role presenelin 1 has in regulating PSAP-induced
programmed cell death and with other Alzheimer's disease protein structures such as amyloid
plaques and neurofibrillary tangles. This study will contribute to understanding the pathological
function of presenilin 1 and will provide new insight into the mechanism of Alzheimer's disease .
This study may also lead to the identification a new therapeutic target of Alzheimer's disease
treatments.
Dr. Xu's studies in exploring the role of apolipoprotein E in ~ amyloid peptide formation
suggests that these substances bind together to form complexes that interfere with the function of
a critical enzyme a-secretase. The binding of apolipoprotein E to newly generated ~ amyloid
peptide also may play a role in determirring whether the latter is deposited or cleared. These
studies will lead to a better understanding of the nlechanism by which the apolipoprotein E is
involved in Alzheimer's disease .
Dr. Xu's experiments are conducted with laboratory models, including brain
(glial) cells containing the genes of apolipoprotein E and for amyloid precursur protein
and in a yeast two-hybrid system. Because mutations in the presenilin 1 gene are
associated with the majority of familial Alzheimer's disease, these studies may provide
important information for the early diagnosis and therapy ofthis disease.
Dr. Xu's work is funded by grants from the National Institutes of Health, Sigma
Kappa and by the Alzheimer's Association. He receives support also from the Center of
Excellence.

VASCULAR BIOLOGY LABORATORY

Dr. Mei-Zhen Cui
Staff: Guojun Zhao
Dr. Cui's work involves the understanding of nlechanisms underlying the
development of vascular diseases including atherosclerosis and thrombus development.
Specifically, their project is focused on elucidating the mechanism by which certain
substances (lipoprotein and lipid) regulates production of an important protein (tissue
factor) involved in blood clotting. Knowledge of how lipoproteins regulate tissue factor
could provide new insights into heart attacks since blood clots and high levels of
lipoproteins worsen the disease leading to the heart attacks.
Tissue factor is a cell surface protein that initiates blood clotting and regulates
thrombosis. Enhanced tissue factor production has been observed in smooth muscle cells
in atherosclerotic lesions of blood vessels and in balloon-damaged arteries. It may
accelerate a variety of pathological processes in vessel walls. A high level of a certain
25
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protein in blood [plasma low density lipoprotein (LDL)] is a risk factor for developing
atherosclerosis. However, the relationship among increased lipoprotein, tissue factor
expression and atherosclerosis is not well understood.
They have found that tissue factor production is enhanced by native and oxidized
LDL. This finding suggests that one of the mechanisms by which lipoprotein causes
atherosclerosis is to induce tissue factor production. The objective of their studies is to
determine how lipoproteins, which are large molecules that carry cholesterol and fats in
blood, cause tissue factor to be produced. The hypothesis is that the way lipoproteins
induce tissue factor in cells is distinct from other substances that induce it. They are
trying to define that novel pathway. Most of their discoveries have been made in a cell
that is typically involved in vascular disease, the smooth muscle cell. Various molecular
and genetic approaches have been used to demonstrate that lipoproteins significantly
induced tissue factor production. Their findings have important implications for a
connection between lipoproteins and tissue factor in development of atherosclerotic
lesions. They hope to elucidate factors promoting the development of vascular diseases
and that may suggest novel therapeutic approaches. Recently the Center of Excellence
has started supporting Dr. Cui's research that is primarily funded by the American Heart
Association.

DISSEMINATION OF RESEARCH TO THE GENERAL PUBLIC
Dr. Nancy Howell

III

One important function of the Center of Excellence is to provide information to
the general public. This information may increase the public's awareness of research and
may provide individuals with valuable results that may improve their lives or their
agribusiness.
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To distribute information the College of Veterinary Medicine uses several
methods. A general newsletter is distributed twice a year throughout Tennessee and
beyond, highlighting research activities. Features concerning on-going research, in
addition to results from concluded research projects, are included in the pUblication,
Veterinary News, which is written for general audiences. Features also appear in other
University of Tennessee publications, including UT Agriculture, UT Alumnus and
Tennessee AgriScience.
In addition, news releases are distributed to state media and to regional and
national media. Television and print publications produce numerous features about the
College each year, many related directly to research conducted through the Center of
Excellence. Public displays about the College frequently include highlights of COE
research. Center of Excellence researchers are invited to share their research not only
professionally, but as speakers to commodity groups, civic groups and other interested
individuals.
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Research is a component of the College's web site, including COE projects such
as the tall fescue toxicity research and other research projects.
Dissemmation of research results through the news media helps inform the public
and provides citizens with a better understanding of the practical applications of science
in their daily lives.

PLANS FOR THE FUTURE
Strategic Planning and External Review .
The support provided by the Center for some of our promising investigators
undoubtedly will constitute the embryogenesis of established research programs. It is
anticipated that the extramural funding and other benchmarks will make an incremental
jump again this year as a result of our strategic recruiting over the past two years (see
"Funding Levels").
Dr. G. Michael Shires, Dean and Director of the Center of Excellence in
Livestock Diseases and Human Health retired at the end of the 1999-2000 fiscal year.
The new Dean of the College of Veterinary Medicine, Dr. Michael Blackwell, will serve
as the new Director of the Center. Because the Dean of the College of Veterinary
Medicine has announced the intention to add an Associate Dean for Research to his
administration team, the Assistant Director of the Center likely also will be replaced in
2001. This will represent new management ofthe Center.
The change in leadership should constitute an opportune time for reviewing the
program. Since the Center for Livestock Diseases and Human Health was determined to
be an established Center in 1988, an external review has been done every four years. The
last review was in 1996 and with the departure of the Center's Director, Dean G. Michael
Shires, in 2000 and the assumption of new leadership by the new Dean of the College,
Dr. Michael Blackwell, an external review is being considered for 2001. Preliminary
plans are to invite a team of four experienced researchers from Colleges of Veterinary
Medicine and appropriate research institutions for review of the program and to make
recommendations. The latter will be used to assist in strategic planning by the Center's
leadership with assistance ofcore faculty.
Some issues that ought to be considered in a review of the Center include whether
the focus areas of the Center are still appropriate and addressing the needs of society and
our stakeholders in Tennessee. Another challenge is for the Center to address the
replacing of critical aging equipment and upgrading equipment for molecular research.
These include ultracentrifuges, high performance liquid chromatography equipment, gas
chromatography unit , quantitative PCR and atomic spectrometer. The flexibility of
utilizing the Center's funds to interact with other funded Centers at the University of
Tennessee ought to be considered. This includes the need for a transgenic mouse facility .
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Coping with a 10% Reduction in Funding:
A 10% reduction in funding will substantially impinge on the research
productivity of the center. The funding levels over the last five years have increased very
modestly (8.9% for an annual average of 1.8%) but have not kept abreast with inflation.
Fortunately our faculty have been productive and funding levels have significantly
increased especially in the last part ofthis reporting period. A reduction in funding must
be addressed with an appropriate strategic plan. A reduction in funding can be addressed
perhaps by only two mechanisms, a 10% reduction in all categories of expenditures (or
deeper cuts in specific areas such as elimination of equipment support) or by elimination
of one ofthe focus areas of the Center. The first option is not advisable because many
projects are only partially funded which jeopardizes the potential for successful leverage
into extramural support by the investigator. For the second option, it is envisaged that the
priority of the five focus areas offocus will be revisited. The focus area(s) with the
lowest priority then could be dropped with respect to Center support so that the Center
can continue to focus on, support and promote the remaining areas. This will be a
difficult decision because investigators in each of its focus areas continue to generate
extramural funding .

Coping with a 10% Increase in Funding:

...

.
..
...
...

The Center functions to enhance research in the targeted areas and to leverage
Center funds to help recruit strategic hires. This is achieved by assisting with start-up
packages for new faculty and by providing seed money for existing faculty. Additional
funding could be used to fund an additional focus area or to fund existing areas more
completely than before. The fonner would require review of existing focus areas and of
the potential ofadding new areas such as emerging zoonotic diseases and/or food safety.
However, the second option may be more appealing. Annually, appropriate proposals
are solicited and evaluated using criteria to support the objectives ofthe Center. Many
excellent proposals are received and several are rejected. Most are not fully funded
which impairs the ability of investigators to leverage Center funds into extramural
support. A strategic plan, including the recommendations ofan external review would be
the first step in considering the wisest application ofincreased funding. However, it is
evident that fully funding some or most of the proposals with a high review score may be
the most productive investment of increased funding for the Center.
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TABLE 1
CENTER OF EXCELLENCE IN LIVESTOCK DISE, ASES AND HUMAN HEALTH BENCHMARKS OF FACULTY ACCOMPLISHMENTS
1995~2000

•

Number of:
Articles
Books or Book Cbapters
P ublisbed Pr~eedings
Total Publications
Abstracts
Invited Participation at:
Regional Meetings
National Meetings
Faculty in Center
Number of Visitors

Year 12
(Year 07 as
Accomplished Center)
1995-1996

Year 13
(Year 08 as
Accomplished Center)
1996-1997

Actual

Actual

Ave:

153
5
65
223
64

(7.29)
(0.27)
(2.95)
(10.62)
(3.05)

55
70

(2.62)
(3.18)
22
18

Ave:
176
5
71
249
71
68
76
24
18

(7.33)
(0.21)
(2.96)
(10.38)
(3.0 11
(2.83)
(2.92)

Year 14
(Year 09 as
Accomplished
Center)
1997-1998
Actual
Ave:

Year 15
(Yearl0as
Accomplished
Center)
1998-1999
Actual
Ave:

Year 16
(Year 11 as
Accomplished Center)
1999-2000

Actual

Ave:

179
104
72
355
56

(11.2)
( 6.5J
( 4.5)
(22.2)
( 3.5)

131
16
42
189
71

(9.4)
(1.1)
(4.5)
(22.2)
(3.5)

89
10
18
117
20

(5.24)
(0.63)
(1.13)
(7.31)
(1.25)

76
74

( 4.8)
( 4.6)

43
62

(4.8)
(4.6)

53
44

(3.31)
(2.75)

16
19

14
11

16
12
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TABLE 2
RESEARCH PROJECTS FUNDED EXTERNALLY
REPORT PERIOD 1999-2000

TOTAL AWARDED

PROJECT DIRECTOR

TITLE OF GRANT

FUNDING AGENCY

Frank Andrews

Pathogenesis of acid injury in the glandular and
non-glandular region of the equine stomach.

Comparative Gastroenterology Society
Research

$5,000.00
0710 1198-07/01/00

o

Pathogenesis of acid injury in the non-glandular
region of the equine stomach.

Grayson-Jockey Club Research
Foundation

$37,110.00
04/01/99-03/3110 t

$24,035.58

Funding for a summer veterinary student and a
clinical project: Determination of maintenance
energy requirements of client-owned dogs

Ralston Purina

$10,000.00
05/24/99-08/31100

$2,091.86

Comparison of two dietary approaches for
managing canine chronic renal failure

lams

$29,522.00
04/01/99-07/01/02

o

Pentosan polysulfate sodium in the treatment of
idiopathic feline lower urinary tract disease.

DVM Pharmaceuticals

$133,112.00
09112197-08/31101

$58,909.35

Influence of diet on urine saturation with struvite in
healthy cats

Ralston Purina

$9,594.00
10/01/97-10/31100

$4,824.59

Influence of diet on glycemic control in dogs with
spontaneous insulin-dependent diabetes mellitus

Ralston Purina

$6,093.00
10/01197-10/31100

$4,463.88

Influence of alkalinization on urinary saturation
with calcium oxalate and struvite, and bone mineral
density in cats

Morris Animal Foundation

$25,000.00
09/01197-03131100

$8,079.07

APR studies

HiHs Pet Nutrition

$13,500.00
11/01197-10/3 1199

o

Antibody response to Bordetella bronchiseptica
chimeric fimbrial protein antigen

USDA 1433 Funds

$12,000.00
09/30/99

$2,354.31

Joseph Bartges

David Bemis

10/01/98

ESTIMATED
EXPENDITURES
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Bovine coronavirus vector for mucosal immunity to
phaemolytica leukotoxin

USDA

$140,000.00
09/15/95·09/30/00

$55,444.58

Mechanism(s) of coronavirus RNA replication and
packaging

National Institute of Allergies and
Infectious Diseases

$586,309.00
07/01/96-06/30/01

$70,420.63

Mei-Zhen Cui

Scientist development award

American Heart Association

$240,000.00
01101/98-12/31/01

$48,889.97

James Godkin

The role of retinol in oocyte maturation and early
embryonic development.

USDA

$215,000.00
09/01199-08/31103

$19,969.00

Stephen Kania

Serum neutralization of bovine virus

Pfizer

$6,400.00

$6,887.54

Laboratory tests for vaccine development

Pfizer

$5,000.00
7/15/99-7/31/00

$13,701.21

Ophidian paramyxovirus infection

American Zoo & Aquarium Assoc

$16,900.00
10/01/98-9/30100

$11,739.49

A recombinant orotein based TSH assay

American Kennel Club

$33,796.00
05101197·09/30/99

$28,220.00

Effects of environment and management on
persistence of antibiotic resistance in bacteria from
swine

The International Life Science Institute

$62,789.00
09/01199-08/31100

$18,771.00

Resistance patterns on swine farms using or
excluding antimicrobial products

National Pork Producers Council

$22,490.00
10/01198-12/31199

$15,549.00

Effect of drug combinations and regimens of
antibiotic resistance

National Pork Producers Council

$24,090.00
10/01/98-09/30/99

$1,812.00

David Brian

Alan Mathew
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Michael McEntee

John New

Jack Oliver
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Effect of n-3 and n-6 polyunsaturated fatty acids on
growth and progression of prostatic cancer in vivo

DOD-Army

$312,938.00
04/15/00-05/14/03

$940.36

In vivo effects of resveratrol during early stages of
intestinal tumorigenesis

American Institute of Cancer Research

$75,952.00
07/01/99-06/30/01

$12,302.51

Dietary effects of a variety of fatty acid ethyl esters
on the formation and development of intestinal
polyps in the Min/+ mouse model when provided in
the context of a western diet

Monsanto (Co-PI)

$71,656.00
01101/99-0110 I /00

$71,656.00

Delta-6 desaturase inhibition and intestinal
tumorigenesis

Monsanto (Co-PI)

$7,150.00
6/99-1/00

$7,150.00

Role of arachidonic acid and PGE2 as key
mediators of intestinal tumorigenesis in vivo

American Institute of Cancer Research
(Co-PI)

$158,484.00
7/99-6/01

$82,000.00

The feasibility of behavioral counseling to promote
successful puppy adoptions

Morris Animal Foundation

$34,700.00
07/16/97 -06/30/99

$7,350.39

The feasibility of behavioral counseling to promote
successful puppy adoptions

PetsMart Charities
$10,000.00
1% 1/97-09/30/99

0

Reactivity of bovine vasculature to Ergovaline and
Ergine of toxic tall fescue

USDA

$188,000.00
10/01/97-09/30/00

$87,731.35

Assessment of inflammatory and immunologic
response of cattle to tall fescue toxins

USDA 1433 Funds

$3,000.00
1% 1/98-9/30/99

$500.00

Pathophysiologic studies of tall fescue toxins in
cattle

USDA 1433 Funds

$6,000.00
10/1/99-09/30/00

$389.31
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Sharon Patton
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Rapid, specific test for salmonella subtypes

National Pork Producer's Council

$29,150.00
06/01/99-07/3 1/00

$26,221.00

Safety specific immune responses and protection in
experimentally infected dairy cows

Pfizer

$165,000.00
04/01/99-12/31/00

$1,400.00

Reproductive performance and reproductive
disorders in Jersey cows

American Jersey Cattle Club

$6,250.00
04/01/99-04/01/00

$46,812.00

Development of chronic streptococcus uberis
intramammary infections in lactating dairy cows

Pharmacia and Upjohn

$56,258.00
01/01/99-12/31/00

$15,341.00

Evaluation of specific immune responses and
protection by streptococcal uberis antigens in
naturally infected dairy cows

Pfizer

$245,624.00
06/01/98-12/31199

$64,318.00

Evaluation of the Uterine Environment During
Clinical Mastitis in Lactating Jersey Cows

American Jersey Cattle Club

$5,500.00
04/01/00-04/01/01

$2,010.00

Model for Determining Effects of Mastitis on
Reproductive Performance in Jersey Cattle

American Jersey Cattle Club

$4,250.00
04/01/99-03/31/00

$4,250.00

Evaluation and use ofBAM/FDA and rapid
microbiological methods for on-farm surveys

Food and Drug Administration

$475,610.00
09/30/98-09/29/01

$120,545.71

Field Test for Diagnosing Toxoplasma gondii in
Swine

National Pork Producer's Council

$18,435.00
10/01/98-06/30/00

$13,265.22
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Hildegard Schuller
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$124,746.00
open

$8,572.72

National Institute of Allergy and
Infectious Diseases - NIH

$1,065,526.00
06/01/95-05/31/00

$225,460.14

Mechanisms of herpetic stromal keratitis

National Eye Institute

$1,296,345.00
09/30/97-09/29/02

$205,778.43

Biodelivery sciences

Biodelivery Sciences

$12,000.00
open

$3,252.27

HSP peptide complexes as a putative vaccine
against herpes simplex virus

Antigenics Agency

$16,620.00
04/15199-04/14/00

0

Vaccination against herpes simplex virus

National Institute of Allergy and
Infectious Diseases- NIH

$1,396,346.00
03/01100-02/28/05

0

Transplacental pancreatic carcinogenesis by NNK

National Institute of Health

$1,001,479.00
08/01/96-07/31/01

726,399.83

Effects of the phosphodiesterase inhibitor B9302
107 on the nasal cavity in hamsters. mice and rats

BYK Gulden

$40,360.00
04/01/98-03/31100

$40,360.00

FACS Vantage SE Cell SorterlFlow Cytometer

National Center for Research Resources

$150,000.00
04/01100-03/31101

0

Herpes zosterfilization

Smith-Kline Biological

Immunity mechanisms in herpesvirus infections

NIH
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Development of a bioremediation risk assessment
scheme

US Environmental Protection Agency

Microbial transformation and molecular toxicology
of estrogens
The Role of bioavailability in determining
acceptable limits for the bioremediation of
polychlorinated biphenyls

I

• • • • ,
$59,199.00
09/94-09/98

$20,000.00

Water Resources Research Institute

$295,334.00
12/07/98-12/06/00

$64,036.00

U.S. Department of Energy

$441,037.00
01/01/97-05/31/00

$160,053.00

$6,600.00
1110199-10/31101

0

$25,400.00
09/01/97 -10/31/00

$25,397.00

Proctor and Gamble
Ecotoxicity of organic chemicals
University of Mississippi
Degradation of natural estrogens in wastewater
treatment facilities

David Slauson

Cellular Pathobiology of Environmental Disease

NIH

$590,897.00
07/01/95-06/30100

$218,931.17

Carla Sommardahl

Molecular analysis of PKD in the TGN737RPW
mouse

NIH

$422,121.00
07/01/97 -07/01/01

$177,474.72

Hwa-Chain Wang

Pathway leads to apoptosis in SCR-transformed
cells

NIH

$517,520.00
01/01/98-12/31/02

$128,162.21

Biochemical evaluation of the functionality of
mutated TBR-ll and TBR-I receptors

Ohio State University

$192,453.00
09/15/98-06/30103

$26,755.67

Role of APOE in beta amyloid formation

Sigma Kappa

$30,000.00
11/01/98-10/31/00

$10,245.86

Role of apoE App processing

Alzheimer's Association

$80,000.00
08/01/98-12/31/00

$2,425.21

Role of apolipoprotein in AD amyloid formation

National Institute ofNeurological Disease
and Stroke

$677,968.00
05/01199-04/30/02

$99,354.58

$11,946,613.00

$3,103,004.72

Xuemin Xu

TOTALS
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Figure 1
CENTER OF EXCELLENCE FOR LIVESTOCK DISEASES AND HUMAN HEALTH EXTERNAL
FUNDING EXPENDITURE LEVELS FOR 1995-2000
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Schedule 7

Budget Form 1997-98

CENTERS OF EXCELLENCE/CENTERS OF EMPHASIS
ACTUAL, PROPOSED, AND REQUESTED BUDGET
Institution

__V_et_e_rl_n_ary.L-M_e_d_ic_ln_e_ _ _ _ _ _ _ _ _ _ _ _ _ _ Center

LIvestock Diseases and Human Health

..

-

668
Other Professional
Clericall Su

Total Salaries

-

41,939
20,081

Assistantsh

-

112,806

225,950

1,029

2,062

3,091

2,234

4,475

6,709

0

450

904

1,354

0

653

89,088

133741

73,488

182,686

51,615

60

-

..

20,937

1 332

4,772

9,560

14,332

6.901

454

909

1,363

400

4,000

207,675
103,385
16
800

155,000

56,610

113,390

23,316

741

17,509

1,200

800

170,000

2,400

Consultants

0

0

0

Renovation

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

37

..

..

CENTERS OF EXCELLENCE/CENTERS OF EMPHASIS
ACTUAL. PROPOSED, AND REQUESTED BUDGET

Institution
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Budget Fonn 1D98-99

Schedule 7

__'c_'ne
_________________________ Cen.r

_1I_.ge~O_f_V_._w_n_n_ary~M_ed

Livestock Diseases and Human Health

29,542

57,084

326

72,653

518

1 035

279

559

838

0

99

197

296

0

Clerical! S

Total Salaries

128,865

77,337

73.654

247

7,278

14,555

160,154

12,802

7,452

21,833

7,667

7,824
15,333

8,050

23,473
100

24,150

..

-
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Schedule 7

Budget Form 1999-00

CENTERS OF EXCELLENCE/CENTERS OF EMPHASIS
ACTUAL, PROPOSED, AND REQUESTED BUDGET

Institution

__v...e_te_rl_n_ary_M_e_d_lc_in_e_ _ _ _ _ _ _ _ _ _ _ _ _ _ Center

Livestock Diseases and Human Health

..

-..
-

-

Renovation

o
o

o

o

o

o

..

..

-

-..
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-

Schedule 7
CENTERS OF EXCELLENCE/CENTERS OF EMPHASIS
ACTUAL, PROPOSED, AND REQUESTED BUDGET
Institution

___V~e~te~r~in~a~ry~M~e~d~ic~i~ne~_____________________________ Center

Livestock Diseases and Human Health

..

..

-

itures

667
Other Professional

61 333
89118

Clericall

Total Salaries

..
..

0
0
0
34

145

57

500

12

750

..

..

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

..

-

40

-

CENTERS OF EXCELLENCE/CENTERS OF EMPHASIS
ACTUAL, PROPOSED, AND REQUESTED BUDGET
__~C~o~lIeg~e~o~f~V~M~e~rl~na~ry~Med~I~c~ln~e________~__________ C~

Institution

-

-..
..

-

-..
-

-

-

-

Livestock and Human Health

I

'"

<::':"'/{;'(:
, " :' ',:o'

>/~,":""

~"':·i""·:,;:;::\,?":";:;",,,;· .. ,,,,.,;,;ii

1999-2000 Actual"

,,':

.'

Matct)lng "ApPropr~

IExpenditures

;,,'.t

"f':';", "

"~J,

"'2000-2001 Propo~~ ..'

'"

'

,

Total

Matching

'.', '

:.

,

"'::~i:l'r"", ";,,""'~;',ur'''f) ~ ~"

'''j

'.§~< ~.: .>.~;~~.~~.:.:~~.~,.>~-.,"

Appropr.

,Total

"I"

:'1l'\~1!,!!'t~~ >

:;,::t','~1il2fxi2~:R~J~;;~~;~~~\< ;:

.: ,

,..~'

1('.'1": f(

';~rTQ"I:>

Matchlna·',·:Appropr.

260,550

521,100

781,650

265,250

530,500

795,750

278,082

557,456

835,538

Faculty

28,544

57,220

85,764

37,463

75,099

112,562

31,672

63,492

95,164

Other Professional

54,888

110,030

164,918

n.316

154,992

232,308

81.182

162,741

243,923

ClericaV Supporting

12,303

24,662

36,965

9.762

19,570

29,332

10,250

20,548

30,799

Assistantships

18,255

36,595

54,850

20,015

40,122

60,137

21,015

42,128

63,144

113,989

228,508

342,497

144,556

289,783

434,339

144,120

288,910

433,030

1,327

2,660

3,987

1,331

2,669

4,000

1.398

2,802

4,200

25,737

51,595

n,332

31,792

63,731

95,523

31,695

63,538

95,233

',' '141.054,

282.782'

423.818

177,879

358.183

633.882

1,126

2,258

3,384

1,331

2.669

4,000

o

Software

o

o

o

o

o

o

o
o

Books & Journals

o

o
o

o
o

o

o

o

o

o

o

o

Other Supplies

41.627

83,446

125,073

50,112

100,457

150,569

34,333

68,824

103,157

Equipment

37,785

75,746

113,531

62.369

125,029

187,398

52.558

105.360

157,918

Maintenance

10,340

20,728

31,068

13,313

26,687

40,000

13,978

28,022

42,000

Scholarships

2,129

4.267

6,396

3,328

6,672

10,000

o

o

Consultants

o

o

o

Renovation

o

o

o

7,276

10,906

o
o
o

o

o

o

o
o

o

o
o

o
o

o

o
o

o
o
o
o

o
o

3,630

o
o
o
o

o
o
o

o
o
o
o
o
o

o

o

0

o

o

o

0

0

0

557,025

557.025

Salaries

Total Salaries

Longevity
Fringe Benefrts
:/:+~~::";'!'~:~~'~~i.~··::·>·~,;{"; . r'~

•

;"':?Total~""nnel

Non-Personnel

Travel

Other (Specify)

, 'I·') ;"~'.

'183.722", 290.358
',
'"
478;484
714,174

,".,:

,"""

130,454

.'
281.513

...

308,133

, 817,896

Revenue
New State Appropriation

521,100

521.100

530.500

530,500

42,104

42,104

86,720

86,719

I"'Qlll"'''''' \::)'(.81e

Appropriation
New Matching Funds
[Carryover from PrevIOus
Matching Funds

260,550

260,550

265,250

265,250

21,050

21,050

43,360

43,360

844,804

308,810

~:¥~;~:~;;~~~:;'/,;\ "28;;~

563,204

617,220

o
278,513

278,513

925,829
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